Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2019 Nov 7;14(11):1626-1633.
doi: 10.2215/CJN.02610319. Epub 2019 Sep 20.

Serum Phosphate and Microvascular Function in a Population-Based Cohort

Affiliations
Observational Study

Serum Phosphate and Microvascular Function in a Population-Based Cohort

Charles Ginsberg et al. Clin J Am Soc Nephrol. .

Abstract

Background and objectives: Higher serum phosphate is associated with cardiovascular events and all-cause mortality. Explanations of this association have focused on large vessel calcification and stiffness. Studies suggest that a higher serum phosphate induces microvascular dysfunction, but relationships in humans with direct measures of microvascular function are lacking.

Design, setting, participants, & measurements: We performed a cross-sectional analysis of 3189 community-living participants that underwent skin capillaroscopy, laser-Doppler flowmetry, and flicker light-induced retinal vessel responses. We used linear regression to assess the association between serum phosphate and each microvascular outcome. The primary outcome was skin capillary recruitment during postocclusive peak reactive hyperemia by capillaroscopy. Secondary outcomes included capillary recruitment during venous congestion, heat-induced skin hyperemic response, flicker light-induced retinal arteriolar, and venular dilation.

Results: The mean age of the cohort was 59±8 years, 48% were women, 7% had an eGFR <60 ml/min per 1.73 m2, and the mean serum phosphate concentration was 3.2±0.5 mg/dl. A 1 mg/dl higher serum phosphate was independently associated with a 5.0% lower postocclusive capillary recruitment (95% CI, -10.0% to -0.1%). Results were similar for capillary recruitment with venous congestion (-4.5%; 95% CI, -9.8% to 0.7%). A 1 mg/dl higher serum phosphate was also independently associated with a 0.23% lower retinal venular dilation in response to flicker light (95% CI, -0.44% to -0.02%). A higher serum phosphate was not associated with change in flicker light-induced retinal arteriolar dilation or heat-induced skin hyperemic response, however a higher serum phosphate was associated with a lower heat-induced skin hyperemic response among men (-149% [95% CI, -260 to -38] per 1 mg/dl higher serum phosphate) but not women (P interaction, 0.01).

Conclusions: Higher serum phosphate concentrations, even within the normal range, are associated with microvascular dysfunction in community-living individuals.

Podcast: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2019_09_20_CJN02610319.mp3.

Keywords: arterioles; capillaries; capillaroscopy; cohort studies; cross-sectional studies; dilatation; endothelium; female; hot temperature; humans; hyperemia; laser-Doppler flowmetry; linear models; male; microscopic angioscopy; microvascular dysfunction; phosphate; phosphates; reference values; retinal microvessels; retinal vessels; venules.

PubMed Disclaimer

Figures

None
Graphical abstract
Figure 1.
Figure 1.
Maastricht population for each microvascular end point. BMI, body mass index; LDF, laser-Doppler flowmetry.
Figure 2.
Figure 2.
Percentage capillary recruitment during postocclusive reactive hyperemia is lower at higher phosphate quartiles. Phosphate quartile ranges were (Q1) 1.6–2.8 mg/dl, (Q2) 2.9–3.2 mg/dl, (Q3) 3.2–3.6 mg/dl, and (Q4) 3.6–5.2 mg/dl. Values presented are adjusted for age, sex, smoking status, 24-hour ambulatory systolic BP, use of antihypertensives, use of lipid modifying agents, diabetes status, eGFR, and serum calcium.

References

    1. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208–2218, 2004 - PubMed
    1. O’Seaghdha CM, Hwang SJ, Muntner P, Melamed ML, Fox CS: Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease. Nephrol Dial Transplant 26: 2885–2890, 2011 - PMC - PubMed
    1. Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, Young B, Sherrard DJ, Andress DL: Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16: 520–528, 2005 - PubMed
    1. Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G; Cholesterol And Recurrent Events Trial Investigators : Relation between serum phosphate level and cardiovascular event rate in people with coronary disease [published correction appears in Circulation 116: e556, 2007]. Circulation 112: 2627–2633, 2005 - PubMed
    1. Foley RN, Collins AJ, Herzog CA, Ishani A, Kalra PA: Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol 20: 397–404, 2009 - PMC - PubMed

Publication types